Impact Of Increasing Rheumatoid Arthritis Prevalence On The Growth Of The Is Supporting Expansion In The Celiac Disease Market

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Projected Increase In Market Value Of The Celiac Disease Market During 2026–2030?

In recent years, the market size for celiac disease has expanded quickly. Forecasts indicate a rise from $0.78 billion in 2025 to $0.87 billion in 2026, with a compound annual growth rate (CAGR) of 10.3%. The growth observed in past periods can be attributed to heightened autoimmune disease awareness, improved diagnostics, the adoption of dietary management strategies, comprehensive hospital gastroenterology care, and dedicated patient advocacy efforts.

The celiac disease market size is anticipated to experience substantial growth over the coming years, with projections indicating it will reach $1.27 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.0%. This expansion during the forecast period is primarily driven by factors like novel drug development, gluten-free food innovation, personalized nutrition, early screening programs, and microbiome research. Significant trends identified for the forecast period comprise the rising adoption of gluten-free diets, an increase in packaged gluten-free foods, the expansion of drug-based therapies, enhanced disease awareness and diagnosis, and a focus on microbiome-based treatments.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24497&type=smp

What Primary Drivers Are Shaping The Celiac Disease Market?

The expansion of personalized medicine is anticipated to propel the growth of the celiac disease market going forward. This healthcare approach customizes medical care based on an individual’s genetic profile, environment, and lifestyle. The demand for personalized medicine is increasing due to the wider availability of genetic testing, which allows for more accurate diagnoses and targeted treatments designed for individual patient needs. The development of personalized medicine supports celiac disease treatment by enabling precise identification of genetic markers and individual immune responses, leading to more targeted and effective management strategies for each patient. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based nonprofit organization, the FDA authorized 16 personalized therapies in 2023 targeting rare diseases, a rise compared to the 6 approved in 2022. Consequently, the growth of personalized medicine will boost the growth of the celiac disease market.

Which Segments Define The Celiac Disease Market Segment Structure?

The celiac disease market covered in this report is segmented –

1) By Treatment: Larazotide Acetate, Gluten Free Diet, Other Treatments

2) By Route Of Administration: Oral, Parenteral

3) By End Users: Hospitals, Homecare, Other End-Users

Subsegments:

1) By Larazotide Acetate: Clinical Trial Phase Products, Oral Capsule Formulation, Adult Celiac Patients, Pediatric Investigational Use, Monotherapy And Combination Therapy

2) By Gluten Free Diet: Packaged Gluten-Free Foods, Gluten-Free Bakery Products, Gluten-Free Snacks, Gluten-Free Nutritional Supplements, Gluten-Free Beverages

3) By Other Treatments: Corticosteroids, Immunosuppressive Drugs, Enzyme Therapies, Monoclonal Antibodies, Probiotics And Microbiome Modulators

What Emerging Trends Are Seen In The Celiac Disease Market?

Leading companies in the celiac disease market are focusing on developing advanced solutions, such as anti-interleukin-15 (IL-15) antibodies, to mitigate tissue damage by limiting excessive immune cell activity. Anti-interleukin-15 (IL-15) antibodies are specialized proteins designed to inhibit the function of the IL-15 cytokine, thereby helping to regulate immune system activity and inflammation. For instance, in May 2025, Teva Pharmaceutical Industries, an Israel-based pharmaceutical company, announced that the U.S. Food and Drug Administration had granted Fast Track status for TEV-53408, an investigational anti-interleukin-15 (IL-15) antibody. This is an investigational monoclonal antibody developed for individuals with celiac disease who continue to follow a gluten-free diet. It functions by blocking interleukin-15 (IL-15), a molecule implicated in triggering the immune response that leads to intestinal harm in celiac patients. The therapy is currently undergoing testing in a Phase 2a clinical trial to evaluate its safety and how effectively it works.

Who Are The Established Players Within The Celiac Disease Market?

Major companies operating in the celiac disease market are Pfizer Inc., Sanofi SA, Novartis AG, Takeda Pharmaceutical Company Ltd., Chugai Pharmaceutical Co. Ltd., Dr Falk Pharma GmbH, Theriva Biologics Inc., Equillium Inc., Immunic Inc., Barinthus Biotherapeutics Plc, Allero Therapeutics, Anokion SA, Mozart Therapeutics, ImmunogenX, Topas Therapeutics GmbH, Parvus Therapeutics Inc., AMYRA Biotech AG, Provention Limited, Precigen Inc., Zedira GmbH, AnTolRx Inc., Nemysis Ltd., Entero Therapeutics Inc.

Get The Full Celiac Disease Market Report:

https://www.thebusinessresearchcompany.com/report/celiac-disease-global-market-report

Which Region Is The Leading Market For The Celiac Disease Market?

North America was the largest region in the celiac disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the celiac disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Celiac Disease Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/celiac-disease-global-market-report

Browse Through More Reports Similar to the Global Celiac Disease Market 2026, By The Business Research Company

Rare Diseases Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-diseases-treatment-global-market-report

Rare Disease Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-disease-diagnostics-global-market-report

Rare Inflammatory Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-inflammatory-disease-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795